Successful Drug Development Despite Adverse Preclinical Findings : Part 2 : Examples

スポンサーリンク

概要

論文の詳細を見る
2010-12-01

著者

関連論文

Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples
Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings
IS IV-1 Regulatory Issues on Pharmaceutical chemicals : revision of ICH S2(Session IV: Regulatory Issues and Risk Assessment)
Message from the President of the Conference
Tissue Sample Preparation for In Vivo Rodent Alkaline Comet Assay
Differences in micronucleus induction in peripheral blood reticulocytes of mice exposed to N-ethyl-N-nitrosourea at light and dark dosing times
A category approach to predicting the hemolytic effects of ethylene glycol alkyl ethers in repeated-dose toxicity
International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies
Successful Drug Development Despite Adverse Preclinical Findings : Part 2 : Examples
Successful Drug Development Despite Adverse Preclinical Findings : Part 1 : Processes to Address Issues and Most Important Findings
Global Recognition of Qualified Toxicologic Pathologists : Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
A new parameter that supports speculation on the possible mechanism of hypothyroidism induced by chemical substances in repeated-dose toxicity studies

もっと見る

スポンサーリンク